NOT YET RECRUITING
NCT07804459
Individualized fMRI-guided TMS for Depression
The goal of this clinical trial is to learn how transcranial magnetic stimulation (TMS) affects brain circuits involving the subgenual anterior cingulate cortex (sgACC) in adults with depression. The main questions it aims to answer are:
* Can brain responses in the sgACC before treatment predict improvement in depressive symptoms following TMS?
* Does a 6-week course of active TMS, compared with sham TMS, change brain responses in the sgACC?
* Are changes in sgACC responses during treatment associated with changes in depressive symptoms?
Researchers will compare active TMS with sham TMS to evaluate changes in the targeted brain circuit and depressive symptoms.
Participants will:
* Receive active or sham TMS every weekday for 6 weeks
* Undergo MRI scans with TMS before, during, and after the 6-week intervention to measure brain responses to stimulation
* Complete clinical assessments, questionnaires, and cognitive testing
* Complete follow-up assessments after the intervention
Gender: All
Ages: 18 Years - 65 Years
Depression
Major Depressive Disorder (MDD)
Depression - Major Depressive Disorder
+3